SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-009717
Filing Date
2024-02-02
Accepted
2024-02-02 17:03:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 ea192442-s3a1_actiniumpharma.htm S-3/A 322653
2 CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea192442ex23-1_actinium.htm EX-23.1 2233
3 FILING FEE TABLE ea192442ex-fee_actinium.htm EX-FILING FEES 170561
4 GRAPHIC image_001.jpg GRAPHIC 12681
5 GRAPHIC image_002.jpg GRAPHIC 12681
6 GRAPHIC image_003.jpg GRAPHIC 31049
7 GRAPHIC image_004.jpg GRAPHIC 31710
  Complete submission text file 0001213900-24-009717.txt   618459
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-273911 | Film No.: 24592546
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)